Current NDC auxiliary source row compounder:300

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69852-776
Product Ndc: 69852-776
Product Ndc Digits: 69852776
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Dexamethasone Acetate 8 mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Dexamethasone Acetate 8 mg/mL
Dosage Form Name: INJECTION, SUSPENSION
Route Name: INTRAMUSCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Eagle Pharma Outsourcing, LLC
Establishment Name: Eagle Pharma Outsourcing, LLC
Establishment Fei: [empty]
Substance Name: DEXAMETHASONE ACETATE ANHYDROUS
Active Ingredients Info: 80 mg/10 mL
History Active Ingredients Raw: DEXAMETHASONE ACETATE ANHYDROUS
History Active Ingredients Info Raw: 80 mg/10 mL
History Dosage Raw: INJECTION, SUSPENSION
Dea Schedule: [empty]
Package Ndc Raw: 69852-776-10
Package Ndc: 69852-776-10
Package Ndc Digits: 6985277610
Package Ndc11: 69852077610
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (69852-776-10)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:300
Source Row Number: 300
Source Row Hash: 74f5c58662a2a8426989d96ca3b55762e894ed96e83a80b1a1a5f7a6f0f8eac8
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "69852-776",
    "DEASCHEDULE": "",
    "LABELERNAME": "Eagle Pharma Outsourcing, LLC",
    "SUBSTANCENAME": "DEXAMETHASONE ACETATE ANHYDROUS",
    "DOSAGEFORMNAME": "INJECTION, SUSPENSION",
    "NDCPACKAGECODE": "69852-776-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Dexamethasone Acetate 8 mg/mL",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Dexamethasone Acetate 8 mg/mL",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL, MULTI-DOSE (69852-776-10) ",
    "ACTIVEINGREDIENTSINFO": "80 mg/10 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:300
Source Row Number: 300
Status Scope: package
Lookup Ndc: 69852-776-10
Lookup Ndc Digits: 6985277610
Product Ndc: 69852-776
Product Ndc Digits: 69852776
Package Ndc: 69852-776-10
Package Ndc Digits: 6985277610
Package Ndc11: 69852077610
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 74f5c58662a2a8426989d96ca3b55762e894ed96e83a80b1a1a5f7a6f0f8eac8
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38